Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
about
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsElevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosisLipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancerAnti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesisA prospective study of aspirin use and the risk of pancreatic cancer in womenCyclooxygenase-2 and gastric carcinogenesisExpression of cyclooxygenase-2, p53 and Ki-67 in gastric cancerGenetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer riskCombination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I studyInflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancerOncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9Lung Krüppel-like factor (LKLF) is a transcriptional activator of the cytosolic phospholipase A2 alpha promoterInhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humansEpithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis.Influence of age and gender on association between -765G > C COX-2 genetic polymorphism and gastric adenocarcinoma risk: a case-control study in Iran.Melatonin Ameliorates The Production of COX-2, iNOS, and The Formation of 8-OHdG in Non-Targeted Lung Tissue after Pelvic Irradiation.2-(2-Arylphenyl)benzoxazole As a Novel Anti-Inflammatory Scaffold: Synthesis and Biological EvaluationRestoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinomaElevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic CancerCombination of physical activity, nutrition, or other metabolic factors and vaccine responseComparative analysis of clinicopathological correlations of cyclooxygenase-2 expression in resectable pancreatic cancerMonomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposureRole of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinomaSuppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells.A review of the application of inflammatory biomarkers in epidemiologic cancer research.Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.Anti-inflammatory activity of grains of paradise (Aframomum melegueta Schum) extract.Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer modelCyclooxygenase 2 promotes parathyroid hyperplasia in ESRD.Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer.Impact of genomic instability in risk assessment and chemoprevention of oral premalignancies.Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.Celecoxib extends C. elegans lifespan via inhibition of insulin-like signaling but not cyclooxygenase-2 activity.Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention.Upregulation of prostaglandin receptor EP1 expression involves its association with cyclooxygenase-2Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells.Progress and perspectives in chemoprevention of head and neck cancer.Review article: colitis-associated cancer -- time for new strategies.
P2860
Q24631327-A4403DA6-7FBC-433F-9008-1542DB8FFDE7Q24682686-C45E3256-9D66-4FB7-BEFD-DD1B4C6D1861Q24800010-EA90DD68-F674-4F29-9B42-BB3D4EECB3C0Q26745650-1D05F845-DED2-4EB7-92B8-9A0CA105BEC9Q26997809-F50FCABC-D5EC-4CE6-845D-C31F78DE873DQ28166674-C4E322C5-C6B2-4E76-927A-C9A69FCC47C8Q28184447-AFB846A8-FC8B-478D-9B7A-CDAD160EA6B9Q28200724-8ABBA94C-4DFA-40D0-89BD-A22F75CF9630Q28213217-DF875F73-E323-4FFE-8310-20EF09E3399DQ28218423-E0852C91-6E87-4A17-A05B-6F0245730066Q28218639-EDF96929-962F-4509-9155-27FBD8BDBEA4Q28301952-46AFF1DA-8A8F-4698-AEA4-B2CF1FEBC6B3Q28565657-416CF5E0-7CEF-4C02-9BFD-2D4A6F5659F1Q30486725-BC6F49C1-ACDD-487F-A97A-50219E701193Q30545576-BA257F4D-2FE4-471D-89DB-5942AA0E8ED5Q33596371-12574C0E-976E-4614-B676-441A9D5274E5Q33625832-26420BD6-8687-477F-9D80-EBD4F6794BEAQ33636453-E7E86629-DB30-4832-B7A1-9F5272FE29A1Q33646333-C3B77B55-F99D-4E3B-9923-37444B739FEBQ33670223-743B0E57-7E84-4F29-9D98-315458517A34Q33751144-3CB7DD14-189A-428A-AAD5-F2DE1F6D5D4EQ33798878-7C7B35CE-1218-4B11-9D21-4B4284346CF7Q33917979-7DAA0D4D-6EA4-4D76-8A49-D17FE369A8A7Q34021476-44C8B748-4910-48CE-A7D1-C4F7976F02CBQ34032403-DFE66B5F-0803-4AFA-AAC9-7BCF4F60BD66Q34135803-2F698F6F-0324-4302-B13A-77FB67FF4F57Q34156486-93519F94-B768-4720-A170-6E3FD01BF94AQ34419636-AF9E4C2F-EA06-4B2E-B914-509C0286824FQ34432899-7F9040AC-314E-4BF1-9895-8869F74CD038Q34718187-FD383A9A-E454-4454-A154-E2341BE6B5AEQ34726849-60CDA1D3-4BAD-442E-92B9-B2AEF0F329BCQ34804039-CFA42FE3-7D3D-425D-B1F1-1E8A3308B54DQ34810915-54300522-A44C-4C09-BB08-BC8053A20DCCQ34904867-57A7BCBB-946B-4A46-81EC-08DE3DB30250Q34981283-41620248-F6F6-4C47-A790-58FDEECCAE01Q35011895-318AC838-983D-449A-AD7D-42E0FCB2640DQ35116059-4D353692-AB03-4CE9-8C0B-07D460F808F0Q35151018-F22B82E5-B7C3-4514-9063-54DCDFE2DE50Q35160205-CD335CD9-2068-4E90-BC2B-2E076C363DB2Q35209646-13730CB3-08CF-4E0D-816B-A9029166F70E
P2860
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
@ast
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
@en
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
@nl
type
label
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
@ast
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
@en
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
@nl
prefLabel
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
@ast
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
@en
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
@nl
P2093
P1433
P1476
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
@en
P2093
A J Dannenberg
B B Weksler
K Subbaramaiah
N K Altorki
P304
P356
10.1016/S1470-2045(01)00488-0
P577
2001-09-01T00:00:00Z